1.
Study on the value of CEA mRNA detection in diagnosis of malignant ascites
腹水标本癌胚抗原mRNA检测诊断恶性腹水
2.
Practical clinical value of peritoneum biopsy, ascetic tumor-maker and ascetic cytological examination on the differential diagnosis of benign and malignant ascites
腹膜活检在良恶性腹水鉴别中的临床实用价值
3.
Differential Diagnosis of hTERT and VEGF to Benign and Malignant Ascites;
hTERT、VEGF对良恶性腹水的鉴别诊断
4.
Diagnostic Value about the Level of CA153 and CA99 in the Malignancy-Relted Ascites
CA153和CA19-9对恶性腹水的诊断价值
5.
Oberserveation on the therapeutic effect of rmh-TNF in treating malignant ascites
RmhTNF治疗恶性腹水疗效观察
6.
Research advances of CD4~+ CD25~+ regulatory T cells in malignant ascites
CD4~+ CD25~+调节性T细胞与恶性腹水的相关研究进展
7.
The Tests for Anti-TB and Adenosine Deaminase in Ascites for Distinguishing Between Tuberculous Ascites and Carcinous Ascites
腹水腺苷脱氨酶和结核抗体检测对鉴别恶性腹水及结核性腹水的价值
8.
The Significance of Incorporating Ascites Measurement for the Differentiation of Malignancy-related and Nonmalignant Ascites;
联合检测多项指标对良恶性腹水鉴别的意义
9.
The differential diagnostic value of hTERC oncogene in benign and malignant ascites by fluorescence in situ hybridization
hTERC基因的FISH检测对良恶性腹水鉴别诊断的价值
10.
Clinical Significance of Measuring the Levels of MMP-2 MMP-9 in Ascites
基质金属蛋白酶-2、-9在恶性腹水中的表达
11.
STUDY ON THE EXPRESSION OF CARCINOEMBRYONIC ANTIGEN MRNA IN MALIGNANT ASCITES AND BENIGN ASCITES
良恶性腹水表达癌胚抗原信使核糖核酸的差别
12.
The Intervention of AgNOR on Malignant Ascites with Method of Fuzheng Combined Intraperitoneal Chemotherapy
扶正法结合腹腔化疗对小鼠恶性腹水细胞AgNOR的干预作用
13.
Clinical analysis of chemotherapeutic intraperitoneal perfusion combined with local high freguency hyperthermia for the treatment of malignant ascites
腹腔灌注化疗联合局部高频热疗治疗恶性腹水的临床分析
14.
Application value of the detection of telomerase activity and DNA aneuploid in ascites for the diagnosis of malignant ascites
检测端粒酶活性和DNA异倍体对恶性腹水诊断价值
15.
Anti-tumor Activity of Cationic Liposomes Combined with Adenovirus Containing Murine EBV-induced Molecule 1 Ligand Chemokine Gene;
mELC重组腺病毒联合缓释脂质体治疗恶性腹水的研究
16.
Adenovirus-mediated IL-12 Gene Therapy in Combination with Cisplatin for the Treatment of Murine Malignant Ascites;
重组mIL-12基因腺病毒联合顺铂治疗小鼠恶性腹水的实验研究
17.
Alginate-Encapsulated Producer Cells: A Potention New Approach for the Treatment of Malignant Ascites;
藻酸盐包裹MIP-3α修饰细胞治疗恶性腹水的实验研究
18.
The Differential Diagnostic Significance of Combined DNA Ploidy Analysis and Carcinoembryonic Antigen Assay in Malignant Ascites;
DNA倍体分析联合癌胚抗原测定对恶性腹水的鉴别诊断价值